These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16081028)

  • 1. NOD mice and autoimmunity.
    Aoki CA; Borchers AT; Ridgway WM; Keen CL; Ansari AA; Gershwin ME
    Autoimmun Rev; 2005 Jul; 4(6):373-9. PubMed ID: 16081028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct genetic control of autoimmune neuropathy and diabetes in the non-obese diabetic background.
    Bour-Jordan H; Thompson HL; Giampaolo JR; Davini D; Rosenthal W; Bluestone JA
    J Autoimmun; 2013 Sep; 45():58-67. PubMed ID: 23850635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A defect in central tolerance in NOD mice.
    Kishimoto H; Sprent J
    Nat Immunol; 2001 Nov; 2(11):1025-31. PubMed ID: 11668341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune diabetes-prone NOD mice express the Lyt2 alpha (Lyt2.1) and Lyt3 alpha (Lyt3.1) alleles of CD8.
    Johnson-Tardieu JM; Walworth EW; Cornelius JG; Ye X; Schuster SM; Peck AB
    Immunogenetics; 1996; 43(1-2):6-12. PubMed ID: 8537123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen presenting cells and the immunogenetics of autoimmune diabetes in NOD mice.
    Leiter EH; Serreze DV
    Reg Immunol; 1992; 4(5):263-73. PubMed ID: 1290746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic mice.
    Racine JJ; Zhang M; Wang M; Morales W; Shen C; Zeng D
    J Immunol; 2015 Jan; 194(1):407-17. PubMed ID: 25429069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice.
    Jiang F; Yoshida T; Nakaki F; Terawaki S; Chikuma S; Kato Y; Okazaki IM; Honjo T; Okazaki T
    Int Immunol; 2009 May; 21(5):499-509. PubMed ID: 19261693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
    Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
    Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic control of autoimmune diabetes in the NOD mouse.
    Wicker LS; Todd JA; Peterson LB
    Annu Rev Immunol; 1995; 13():179-200. PubMed ID: 7612220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOD congenic mice genetically protected from autoimmune diabetes remain resistant to transplantation tolerance induction.
    Pearson T; Markees TG; Wicker LS; Serreze DV; Peterson LB; Mordes JP; Rossini AA; Greiner DL
    Diabetes; 2003 Feb; 52(2):321-6. PubMed ID: 12540603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class I and autoimmune diabetes.
    Faustman DL
    Biomed Pharmacother; 1993; 47(1):3-10. PubMed ID: 7872965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced responsiveness to T-cell help causes loss of B-lymphocyte tolerance to a β-cell neo-self-antigen in type 1 diabetes prone NOD mice.
    Cox SL; Stolp J; Hallahan NL; Counotte J; Zhang W; Serreze DV; Basten A; Silveira PA
    Eur J Immunol; 2010 Dec; 40(12):3413-25. PubMed ID: 21108464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-dependent diabetes loci Idd5 and Idd9 increase sensitivity to experimental autoimmune encephalomyelitis.
    Mayo S; Kohler W; Kumar V; Quinn A
    Clin Immunol; 2006; 118(2-3):219-28. PubMed ID: 16301001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The murine autoimmune diabetes model: NOD and related strains.
    Kikutani H; Makino S
    Adv Immunol; 1992; 51():285-322. PubMed ID: 1323922
    [No Abstract]   [Full Text] [Related]  

  • 16. Bridging mice to men: using HLA transgenic mice to enhance the future prediction and prevention of autoimmune type 1 diabetes in humans.
    Serreze DV; Niens M; Kulik J; Dilorenzo TP
    Methods Mol Biol; 2010; 602():119-34. PubMed ID: 20012396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent.
    Serreze DV; Chapman HD; Varnum DS; Gerling I; Leiter EH; Shultz LD
    J Immunol; 1997 Apr; 158(8):3978-86. PubMed ID: 9103469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The targeting of β-cells by T lymphocytes in human type 1 diabetes: clinical perspectives.
    Luce S; Briet C; Bécourt C; Lemonnier F; Boitard C
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():89-97. PubMed ID: 24003925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is lack of peripheral tolerance induction a cause for diabetes in the non-obese diabetic mouse?
    Lund T; Strid J
    Arch Immunol Ther Exp (Warsz); 2000; 48(5):405-16. PubMed ID: 11140468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.